December 20, 2019
As the leading innovator in RNA-targeted therapeutics, Ionis Pharmaceuticals requires world-class scientists and business leaders whose passion to innovate is matched only by their commitment to deliver transformational medicines to patients who need them. Ionis, known for these transformative breakthroughs for patients, relies on the expertise of The Chase Group with 25+ years of executive search experience in the life sciences industry to find their executive talent. Ionis has recently partnered with The Chase Group to find the newest member of their drug safety leadership team. The new Executive Director/Director, Drug Safety will have the opportunity to work with Ionis’ robust pipeline of 40+ first-in-class medicines covering multiple therapeutic areas and be responsible for the clinical safety strategy for assigned drug projects and products while driving proactive implementation of risk management initiatives in accordance with global regulatory requirements. For more information about this position, please contact 913-663-3100 or ken@chasegroup.com.
